Artificial Intelligence software assists Dresden Radiology in detecting breast cancer at an early stage

The University Hospital Carl Gustav Carus Dresden has made a significant stride in the field of breast cancer diagnostics by introducing AI-based software "Transpara" in its mammography services since November 2023. The hospital is the first facility in the Dresden region to adopt this technology, marking a new era in diagnostics.

Breast cancer, or mammary carcinoma, is the most common malignant tumor in women in Germany, with around 70,000 new cases diagnosed annually. Early detection is crucial for increasing survival chances, and the use of AI in mammography is expected to play a pivotal role in this regard.

Prof. Ralf-Thorsten Hoffmann, Director of the Institute and Policlinic for Diagnostic and Interventional Radiology, explains that "Transpara" provides radiologists with a 'second pair of eyes', improving reading accuracy in mammography. The AI software reliably detects even the smallest nodes and calcifications in mammography images, reducing the risk of false diagnoses, a significant goal in the development of AI for breast cancer detection.

The software compares the images with a database of over five million pictures for faster diagnosis, saving time and personnel resources at the University Hospital. Prof. Michael Albrecht, Medical Director of the University Hospital, states that the use of AI in diagnostics is becoming a standard and sets a new standard in modern therapies and diagnostics.

The University Medicine Dresden plans to further evaluate the application of AI in practice in the coming years. The different breast densities in women should be given more attention in future iterations of AI software. The future development of Artificial Intelligence is hoped to lead to faster and more reliable breast cancer detection, ultimately improving the prognosis for patients.

The initiator of the application of artificial intelligence in mammography at the Carl Gustav Carus University Hospital Dresden in November 2023 is not specified in the available search results. However, the adoption of AI in mammography diagnostics provides additional security and is expected to become the standard in diagnostics in the future.

It is estimated that one in eight women is affected by breast cancer in her lifetime. The earlier the diagnosis, the higher the chances of survival for patients. The University Hospital Dresden's adoption of AI-based software "Transpara" is a significant step towards earlier and more accurate breast cancer detection, ultimately improving the lives of many women.

Artificial Intelligence software assists Dresden Radiology in detecting breast cancer at an early stage